Dexmethylphenidate HCl regulatory update

The companies received an approvable letter from the FDA for dexmethylphenidate (d-MPH), a chiral d-enantiomer of NVS's Ritalin, to treat attention deficit hyperactivity disorder (ADHD). NVS has worl...